BOSTON, Massachusetts, May 31 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release: * * * Perioperative Apalutamide in High-Risk Localized or Locally Advanced Prostate Cancer Reduces Risk of Metastasis and Death * High-risk localized and locally advanced prostate cancer patients treated with apalutamide -a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI) -plus hormone therapy before and after prostate cancer surgery resulted in m  more

WASHINGTON, May 29 -- The Senate Commerce, Science and Transportation Committee released the following written testimony by Harry Levant, director of gambling policy at the Public Health Advocacy Institute, from a May 20, 2026, hearing entitled "No Sure Bets: Protecting Sports Integrity in America": * * * Chairman Cruz, Chairman Blackburn, Senator Cantwell, Senator Hickenlooper, and members of the Subcommittee on Consumer Protection, Technology, and Data Privacy, thank-you for the opportunity   more

LOS ANGELES, California, May 31 [Category: BizHospital] -- Cedars-Sinai, a nonprofit academic healthcare organization, posted the following news: * * * Study: New Drug Could Dramatically Increase Pancreatic Cancer Survival * A new medication could double survival time in patients with advanced pancreatic cancer, according to Phase III clinical trial results presented at the American Society of Clinical Oncology (ASCO) 2026 annual meeting and simultaneously published in The New England Journa  more